Skip to main content

Multicenter evaluation of a bilayer polymer blood collection tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers.

Toulon P, Aillaud MF, Arnoux D, Boissier E, Borg JY, Gourmel C

Publication: Blood Coagul Fibrinolysis (2006) • Vol 17 • Page 625-31PMID: 17102648View on PubMed

Purpose

The purpose of this paper was to determine the effects of tube type, anticoagulant concentration, post-centrifugation delays to analysis, and tube age on routine hemostasis assays and coagulation activation markers in plasma.

Conclusion

No clinically relevant differences were observed in prothrombin time (PT), factor V (FV), activated partial thromboplastin time (APTT), anti-activated factor X (anti-FXa) activity, prothrombin fragment 1+2 (F1+2), or thrombin-antithrombin complexes (TAT) between specimens collected in plastic Vacuette and siliconized glass Vacutainer tubes, between specimens with two different citrate concentrations, between specimens collected in Vacuette tubes at the beginning or end of their shelf life, or in specimens after 6 h post-centrifugation delay to analysis at room temperature.

Studies (1)

Purpose

The purpose of this study was to determine the effects of tube type, anticoagulant concentration, post-centrifugation delays to analysis, and tube age on routine hemostasis assays and coagulation activation markers in plasma. Routine hemostasis assays were performed immediately but plasma was stored at -70 degrees C until analysis of coagulation activation markers. Analysis was completed in 5 different centers using their own analyzers and reagents.

Summary of Findings

Collection of specimens in plastic Vacuette versus siliconized glass Vacutainer tubes, with 0.109 mol/L versus 0.129 mol/L citrate, in Vacuette tubes at the beginning or end of their shelf life, and 6 h post-centrifugation delays to analysis at room temperature did not result in clinically relevant differences in PT, FV, APTT, or anti-FXa activities. Statistically significant variations were seen for these analytes with the different collection and processing conditions that were also dependent on type of anticoagulant therapy. Levels of F1+2 and TAT in plasma were statistically significantly lower in specimens collected in plastic tubes than in glass tubes, but the difference was not clinically relevant.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Not specified
  • Platforms

    ProteinHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    Low molecular weight heparin derivative
    No anticoagulant drugs
    Oral anticoagulants
    Unfractionated heparin
    Biospecimen AcquisitionAnticoagulant
    Multiple concentrations evaluated
    Sodium citrate
    Biospecimen AcquisitionType of collection container/solution
    Vacuette (plastic) 1 month from expiration
    Vacuette (plastic) 11 months from expiration
    Vacutainer (glass)
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)
    StorageTime at room temperature
    0 h
    6 h